Ignite Creation Date:
2024-05-06 @ 3:48 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02379494
Status:
COMPLETED
Last Update Posted:
2017-08-22
First Post:
2014-02-20
Brief Title:
First Trimester Prediction of Preeclampsia and Fetal Growth Restriction
Sponsor:
Organization:
Fetal Medicine Foundation
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
A 5cc maternal blood sample will be obtained through standard blood draw The blood will first be transferred onto a dry blood requisition form card The blood sample will be refrigerated and the serum and dried blood spot samples will be sent to Perkin Elmer Laboratories see attachment C for collection protocols The maternal serum levels of PAPP-A PLGF AFP and free β hCG will be measured according to a protocol established by Perkin Elmer Laboratories
Enrollment Count:
1200
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 29150 |
Who Masked List: